Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?
Despite significant progress in trisomy 21 (T21) diagnostic tools, amniocentesis is still used for the confirmation of an abnormal fetal karyotype. Invasive tests carry the potential risk of miscarriage; thus, screening biomarkers are commonly used before undergoing invasive procedures. In our study...
Main Authors: | Angelika Buczyńska, Iwona Sidorkiewicz, Sławomir Ławicki, Adam Jacek Krętowski, Monika Zbucka-Krętowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2382 |
Similar Items
-
Novel Approaches to an Integrated Route for Trisomy 21 Evaluation
by: Angelika Buczyńska, et al.
Published: (2021-09-01) -
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome
by: Angelika Buczyńska, et al.
Published: (2020-12-01) -
Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
by: Ori Shen, et al.
Published: (2014-04-01) -
Ageing and Olfactory Dysfunction in Trisomy 21: A Systematic Review
by: Hanani Abdul Manan, et al.
Published: (2021-07-01) -
Non-invasive prenatal test to screen common trisomies in twin pregnancies
by: Mahtab Motevasselian, et al.
Published: (2020-02-01)